The US Food and Drug Administration on Thursday granted full approval to the antiviral drug Remdesivir as a treatment for patients hospitalized with Covid-19, its manufacturer Gilead said, following conditional authorization granted in May.
Gilead said the authorization for the drug, sold under the brand name Veklury, was the only specific treatment for Covid-19 approved so far following a more rigorous study.
However, other treatments have received authorization for emergency use.
Gilead’s stock on the New York Stock Exchange jumped 4 percent soon after the announcement.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)